INTERLEUKIN-2 THERAPY - AN OVERVIEW

Just one place mutation, V6A, introduced to the molecule significantly improved the toxicity profile and decreased VLS as compared to the WT molecule [seventy six]. Added experiments and medical trials might be necessary to ascertain if this modified construct has improved protection and efficacy in human beings.From the literature, we might also d